Zymedi Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jun 2038
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 27, 2026The maintenance fee for Antibody binding specifically to N-terminal region of lysyl-tRNA synthetase exposed on cell membrane (US 11,685,791) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
- 1 fee due Oct 23, 2027The maintenance fee for Pharmaceutical composition comprising antibody binding specifically to lysyl-tRNA synthetase N-terminus as effective ingredient for preventing or treating immune cell migration-related disease (US 11,965,038) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 4 of 4
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,378,572 | Therapeutic agent for immune cell migration-caused disease and method for screening same In force · From the USPTO record | In force | From the USPTO record | |
| US 11,965,038 | Pharmaceutical composition comprising antibody binding specifically to lysyl-tRNA synthetase N-terminus as effective ingredient for preventing or treating immune cell migration-related disease In force · From the USPTO record | In force | From the USPTO record | |
| US 11,685,791 | Antibody binding specifically to N-terminal region of lysyl-tRNA synthetase exposed on cell membrane In force · From the USPTO record | In force | From the USPTO record | |
| US 12,679,903 | Antibody for Specifically Binding to Lysyl-tRNA Synthetase N-Terminal Domain Exposed to Extracellular Membrane In force · High confidence | In force | High confidence |
Also on record, not counted in the 4: 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending